Loading stock data...

Aarey Drugs & Pharmaceuticals Limited

BSE: AREYDRG

BSE
61.59 -2.16 (-3.39%)

Prev Close

63.75

Open Price

65.03

Volume

41,549

Today Low / High

61.27 / 65.7

52 WK Low / High

11.5 / 65.7

Range

59 - 65

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 61.59, reflecting a change of -2.16 (-3.3882%). The expected target range on the BSE is 59 - 65. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

No data available

Aarey Drugs & Pharmaceuticals Limited Graph

Aarey Drugs & Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Aarey Drugs & Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 61.59, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 61.59 62.21 55.99 - 68.43
62.82 50.26 - 75.39
63.44 44.41 - 82.47
Bearish Scenario 61.59 60.97 54.88 - 67.07
60.36 48.29 - 72.43
59.74 41.82 - 77.66

Overview of Aarey Drugs & Pharmaceuticals Limited

ISIN

INE198H01019

Industry

Vol.Avg

63,231

Market Cap

1,440,263,673

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

N/A

DCF

0

Financial Ratios Every Investor Needs

Stock Dividend of AREYDRG

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2018-12-13 December 13, 18 0.1 0.1 2018-12-14 2018-12-30

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2023-03-31 417.55 Cr 406.04 Cr 11.51 Cr 0.0276 0.00 Cr 0.00 Cr 9.46 Cr 3.77 Cr 1.49 11.03 Cr 0.0090
2022-03-31 491.67 Cr 474.71 Cr 16.95 Cr 0.0340 0.00 Cr 0.00 Cr 11.77 Cr 6.55 Cr 2.72 13.76 Cr 0.0133
2021-03-31 347.88 Cr 338.97 Cr 8.92 Cr 0.0256 0.00 Cr 0.00 Cr 3.87 Cr 6.51 Cr 2.79 4.79 Cr 0.0187
2020-03-31 297.57 Cr 291.39 Cr 6.18 Cr 0.0208 0.00 Cr 0.00 Cr 2.35 Cr 5.79 Cr 2.48 3.25 Cr 0.0195
2019-03-31 354.49 Cr 342.38 Cr 12.11 Cr 0.0342 0.00 Cr 0.00 Cr 6.90 Cr 6.54 Cr 2.80 7.91 Cr 0.0185

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2023-03-31 0.71 Cr 291.32 Cr 173.92 Cr 117.4084 Cr 37.72 Cr 37.01 Cr 65.18 Cr 13.94 Cr 3.38 Cr 0.00 Cr 1.19 Cr 168.1404 Cr
2022-03-31 0.19 Cr 245.17 Cr 131.53 Cr 113.6373 Cr 14.16 Cr 13.97 Cr 56.12 Cr 14.47 Cr 0.89 Cr 0.00 Cr 6.78 Cr 126.7361 Cr
2021-03-31 0.65 Cr 233.04 Cr 134.18 Cr 98.8605 Cr 18.02 Cr 17.37 Cr 46.93 Cr 14.26 Cr 3.48 Cr 0.00 Cr 0.40 Cr 132.6120 Cr
2020-03-31 0.50 Cr 194.08 Cr 101.74 Cr 92.3462 Cr 17.89 Cr 17.38 Cr 76.20 Cr 12.30 Cr 2.66 Cr 0.00 Cr 0.44 Cr 100.2778 Cr
2019-03-31 0.37 Cr 145.72 Cr 59.16 Cr 86.5526 Cr 16.16 Cr 15.79 Cr 21.25 Cr 12.27 Cr 3.87 Cr 0.00 Cr 0.45 Cr 57.6324 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2023-03-31 -26.6833 Cr 0.4410 Cr 26.7561 Cr -27.7273 Cr 0.5138 Cr 0.5138 Cr -1.0440 Cr 3.7711 Cr 0.0000 Cr 0.0000 Cr -15.1352 Cr
2022-03-31 2.3534 Cr -3.2100 Cr 0.3988 Cr 0.1521 Cr -0.4578 Cr -0.4578 Cr -2.2013 Cr 6.5548 Cr 0.0000 Cr 0.0000 Cr 4.7767 Cr
2021-03-31 2.8966 Cr -2.8793 Cr 0.1296 Cr 0.0173 Cr 0.1470 Cr 0.1470 Cr -2.8793 Cr 6.5143 Cr 0.0000 Cr 0.0000 Cr -1.4646 Cr
2020-03-31 -0.6800 Cr -0.9186 Cr 1.7325 Cr -1.5986 Cr 0.1340 Cr 0.1340 Cr -0.9186 Cr 5.7935 Cr 0.0000 Cr 0.0000 Cr 4.2543 Cr
2019-03-31 -14.4780 Cr -1.2281 Cr 12.6852 Cr -15.7061 Cr -3.0209 Cr -3.0209 Cr -1.2281 Cr 6.5418 Cr 0.0000 Cr -0.2338 Cr -6.4754 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2023-09-30 57.83 Cr 55.67 Cr 2.16 Cr 0.0370 1.44 Cr 0.78 Cr 0.31 1.85 Cr 0.0136
2023-06-30 50.96 Cr 48.55 Cr 2.41 Cr 0.0470 0.92 Cr 0.72 Cr 0.29 1.34 Cr 0.0142
2023-03-31 158.18 Cr 158.29 Cr -0.11 Cr -0.0010 -2.38 Cr 0.36 Cr 0.14 -2.18 Cr 0.0023
2022-12-31 62.47 Cr 59.35 Cr 3.12 Cr 0.0500 0.98 Cr 0.49 Cr 0.19 1.53 Cr 0.0079
2022-09-30 76.26 Cr 71.28 Cr 4.98 Cr 0.0650 3.86 Cr 2.12 Cr 0.83 4.27 Cr 0.0278

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2023-09-30 1.17 Cr 6.29 Cr 1.17 Cr 109.54 Cr 22.37 Cr 217.98 Cr 13.23 Cr 233.99 Cr 115.07 Cr
2023-03-31 0.71 Cr 0.42 Cr 1.12 Cr 199.71 Cr 65.18 Cr 270.58 Cr 13.94 Cr 291.32 Cr 173.92 Cr
2022-09-30 0.12 Cr 5.12 Cr 0.12 Cr 132.78 Cr 20.50 Cr 209.77 Cr 14.29 Cr 228.43 Cr 111.88 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
No quarterly financial cash flow statement data available.

Splits History

Date Label Split Ratio
2017-10-12 October 12, 17 10:1
2012-06-25 June 25, 12 6:5

Industry not found. Cannot fetch stock data.